Success Metrics

Clinical Success Rate
87.8%

Based on 166 completed trials

Completion Rate
88%(166/189)
Active Trials
175(41%)
Results Posted
23%(39 trials)
Terminated
23(5%)

Phase Distribution

Ph not_applicable
246
58%
Ph phase_4
3
1%
Ph early_phase_1
7
2%
Ph phase_1
19
4%
Ph phase_2
34
8%
Ph phase_3
22
5%

Phase Distribution

26

Early Stage

34

Mid Stage

25

Late Stage

Phase Distribution331 total trials
Early Phase 1First-in-human
7(2.1%)
Phase 1Safety & dosage
19(5.7%)
Phase 2Efficacy & side effects
34(10.3%)
Phase 3Large-scale testing
22(6.6%)
Phase 4Post-market surveillance
3(0.9%)
N/ANon-phased studies
246(74.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

79.8%

166 of 208 finished

Non-Completion Rate

20.2%

42 ended early

Currently Active

175

trials recruiting

Total Trials

424

all time

Status Distribution
Active(209)
Completed(166)
Terminated(42)
Other(7)

Detailed Status

Completed166
Recruiting131
Active, not recruiting44
Not yet recruiting30
Terminated23
Withdrawn19

Development Timeline

Analytics

Development Status

Total Trials
424
Active
175
Success Rate
87.8%
Most Advanced
Phase 4

Trials by Phase

Early Phase 17 (2.1%)
Phase 119 (5.7%)
Phase 234 (10.3%)
Phase 322 (6.6%)
Phase 43 (0.9%)
N/A246 (74.3%)

Trials by Status

unknown41%
recruiting13131%
enrolling_by_invitation41%
not_yet_recruiting307%
completed16639%
withdrawn194%
suspended31%
terminated235%
active_not_recruiting4410%

Recent Activity

Clinical Trials (424)

Showing 20 of 424 trialsScroll for more
NCT06295367Not Applicable

Cost Communication and Financial Navigation in Cancer Patients (COSTCOM)

Recruiting
NCT06945380Not Applicable

Evaluating a Mobile Health Application Intervention for Caregiver Instruction in Manual Therapy for Chemotherapy-Induced Peripheral Neuropathy

Recruiting
NCT07571018Not Applicable

A Novel Mobile Health Intervention for Improving Tobacco Cessation Among Young Adults

Not Yet Recruiting
NCT06909500Not Applicable

A Digital Intervention (ACT on Vaping App) for Vaping Cessation in Young Adult E-Cigarette Users

Not Yet Recruiting
NCT06112613Not Applicable

Mobile Health for Adherence in Breast Cancer Patients

Recruiting
NCT05679349Not Applicable

Support and Outreach to Increase Screening for Lung Cancer in Patients With a History of Smoking

Recruiting
NCT06172296Phase 3

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Recruiting
NCT05256225Phase 3

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

Recruiting
NCT06022939Phase 3

Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis

Recruiting
NCT06950008Not Applicable

A Patient Navigation Intervention for the Improvement of Risk Management Among Women at High Risk of Breast Cancer

Active Not Recruiting
NCT03804255

Assessment of Current Biomarker Testing Practices for Common Solid Cancers in Precision Oncology in the Community Setting

Withdrawn
NCT04829136Not Applicable

Sustained Oral Fiber Supplementation for Patients Undergoing Donor Stem Cell Transplantation for Hematological Malignancies

Recruiting
NCT05702645

A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia

Recruiting
NCT06513962Phase 3

Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer

Recruiting
NCT05705531

A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma

Recruiting
NCT06894979Phase 1

Testing the Addition of an Anti-Cancer Drug, AZD1390, During Radiation Therapy for Newly Diagnosed High Grade Glioma, Diffuse Midline Glioma, or Diffuse Intrinsic Pontine Glioma

Recruiting
NCT05382338Phase 3

A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss

Recruiting
NCT05055011

Parental Attitudes and Beliefs Regarding Risks Associated With Opioid Use in Children With Cancer

Active Not Recruiting
NCT07441681Phase 3

Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin

Not Yet Recruiting
NCT04804644Phase 3

Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking Ability

Recruiting

Drug Details

Intervention Type
OTHER
Total Trials
424